Cryoport Financials
| CYRX Stock | USD 6.38 0.03 0.47% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.42 | 5.2905 |
|
|
Investors should never underestimate Cryoport's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Cryoport's cash flow, debt, and profitability to make informed and accurate decisions about investing in Cryoport.
Net Income |
|
Cryoport | Select Account or Indicator |
Understanding current and past Cryoport Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cryoport's financial statements are interrelated, with each one affecting the others. For example, an increase in Cryoport's assets may result in an increase in income on the income statement.
Cryoport Earnings Geography
Please note, the imprecision that can be found in Cryoport's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cryoport. Check Cryoport's Beneish M Score to see the likelihood of Cryoport's management manipulating its earnings.
Cryoport Stock Summary
Cryoport competes with BioLife Solutions, Caredx, Natera, and IRhythm Technologies. Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was founded in 1999 and is headquartered in Brentwood, Tennessee. Cryoport operates under Integrated Freight Logistics classification in the United States and is traded on NASDAQ Exchange. It employs 900 people.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US2290503075 |
| CUSIP | 229050307 229050208 229050109 |
| Location | Tennessee; U.S.A |
| Business Address | 112 Westwood Place, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.cryoportinc.com |
| Phone | 949 470 2300 |
| Currency | USD - US Dollar |
Cryoport Key Financial Ratios
| Return On Equity | -0.26 | ||||
| Profit Margin | (0.50) % | ||||
| Operating Margin | (0.27) % | ||||
| Price To Sales | 1.40 X | ||||
| Revenue | 228.38 M |
Cryoport Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 552.4M | 1.1B | 1.0B | 957.7M | 703.5M | 738.7M | |
| Other Current Liab | 5.7M | 7.2M | 5.6M | 12.4M | 30.2M | 31.7M | |
| Net Debt | 94.0M | 288.0M | 399.3M | 369.7M | 205.4M | 215.7M | |
| Retained Earnings | (192.0M) | (467.5M) | (542.8M) | (642.4M) | (757.2M) | (719.3M) | |
| Accounts Payable | 24.3M | 27.7M | 27.0M | 26.1M | 27.2M | 28.6M | |
| Cash | 36.9M | 139.1M | 36.6M | 46.3M | 45.3M | 43.0M | |
| Net Receivables | 31.4M | 39.4M | 43.9M | 42.1M | 45.8M | 48.1M | |
| Inventory | 10.5M | 16.5M | 27.7M | 26.2M | 22.5M | 23.6M | |
| Other Current Assets | 23.9M | 17.6M | 9.3M | 10.1M | 11.6M | 17.9M | |
| Total Liab | 169.7M | 471.1M | 482.9M | 468.7M | 301.6M | 316.7M | |
| Total Current Assets | 147.2M | 693.5M | 604.2M | 535.1M | 341.6M | 358.6M | |
| Short Term Debt | 4.6M | 7.2M | 7.8M | 5.8M | 6.1M | 6.4M | |
| Intangible Assets | 213.9M | 201.4M | 191.0M | 194.4M | 170.5M | 86.1M | |
| Common Stock | 37.3K | 40K | 50K | 48K | 49K | 47.5K | |
| Other Liab | 21K | 6.1M | 5.0M | 10.1M | 11.6M | 12.1M | |
| Other Assets | 16.0M | 1.4M | 2.0M | 1.0 | 1.15 | 1.09 | |
| Good Will | 145.3M | 147.0M | 151.1M | 108.4M | 51.7M | 54.2M | |
| Net Tangible Assets | 110.1M | 379.9M | 293.4M | 195.4M | 224.8M | 236.0M | |
| Capital Surpluse | 179.5M | 285.6M | 566.5M | 1.1B | 1.3B | 1.3B |
Cryoport Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 2.6M | 4.7M | 6.1M | 5.5M | 4.1M | 4.3M | |
| Total Revenue | 78.7M | 222.6M | 237.3M | 233.3M | 228.4M | 239.8M | |
| Gross Profit | 36.3M | 96.6M | 103.9M | 99.3M | 99.6M | 104.6M | |
| Operating Income | (30.0M) | (17.8M) | (31.9M) | (115.2M) | (130.9M) | (124.3M) | |
| Ebit | (30.2M) | (269.2M) | (29.0M) | (93.8M) | (109.4M) | (103.9M) | |
| Research Development | 9.5M | 16.8M | 15.7M | 18.0M | 17.7M | 18.6M | |
| Ebitda | (20.3M) | (248.9M) | (6.2M) | (66.4M) | (78.6M) | (74.7M) | |
| Cost Of Revenue | 42.4M | 126.0M | 133.4M | 133.9M | 128.8M | 135.2M | |
| Income Before Tax | (32.7M) | (273.8M) | (35.1M) | (99.3M) | (124.0M) | (117.8M) | |
| Net Income | (32.7M) | (275.5M) | (37.3M) | (99.6M) | (122.8M) | (116.6M) | |
| Income Tax Expense | (45K) | 1.7M | 2.2M | 239K | (1.3M) | (1.2M) | |
| Tax Provision | (45K) | 1.7M | 2.2M | 3.1M | 1.3M | 916.0K | |
| Net Interest Income | (2.6M) | (4.7M) | (6.1M) | (5.7M) | (4.1M) | (4.3M) |
Cryoport Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Cryoport. It measures of how well Cryoport is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Cryoport brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Cryoport had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Cryoport has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 1.3M | (6.0M) | (14.2M) | 1.5M | 234K | 245.7K | |
| Change In Cash | (10.4M) | 102.2M | (102.5M) | 9.8M | (1.1M) | (1.0M) | |
| Free Cash Flow | (24.5M) | (16.9M) | (26.0M) | (45.7M) | (33.6M) | (31.9M) | |
| Depreciation | 9.9M | 20.2M | 22.8M | 27.5M | 30.8M | 32.3M | |
| Other Non Cash Items | 437K | 1.2M | 20.1M | 49.7M | 48.3M | 50.8M | |
| Capital Expenditures | 9.7M | 25.0M | 24.2M | 38.8M | 17.3M | 18.1M | |
| Net Income | (32.7M) | (275.5M) | (37.3M) | (99.6M) | (114.8M) | (109.0M) | |
| End Period Cash Flow | 36.9M | 139.1M | 36.6M | 46.3M | 45.3M | 22.7M | |
| Change Receivables | (2.0M) | (3.6M) | (2.6M) | (7.3M) | (6.5M) | (6.2M) | |
| Net Borrowings | (23.2K) | 110.9M | 36.6M | (3.3M) | (3.8M) | (3.6M) | |
| Change To Netincome | 7.4M | 8.2M | 269.1M | 38.6M | 44.3M | 36.0M | |
| Investments | (9.5M) | (438.7M) | (59.7M) | 57.9M | 176.8M | 185.7M |
Cryoport Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cryoport's current stock value. Our valuation model uses many indicators to compare Cryoport value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cryoport competition to find correlations between indicators driving Cryoport's intrinsic value. More Info.Cryoport is rated fifth in return on equity category among its peers. It is rated third in return on asset category among its peers . At this time, Cryoport's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cryoport's earnings, one of the primary drivers of an investment's value.Cryoport's Earnings Breakdown by Geography
Cryoport Systematic Risk
Cryoport's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cryoport volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Cryoport correlated with the market. If Beta is less than 0 Cryoport generally moves in the opposite direction as compared to the market. If Cryoport Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cryoport is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cryoport is generally in the same direction as the market. If Beta > 1 Cryoport moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Cryoport Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cryoport's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Cryoport growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Cryoport March 17, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cryoport help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cryoport. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cryoport based on widely used predictive technical indicators. In general, we focus on analyzing Cryoport Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cryoport's daily price indicators and compare them against related drivers.
| Downside Deviation | 6.25 | |||
| Information Ratio | 0.0252 | |||
| Maximum Drawdown | 55.19 | |||
| Value At Risk | (10.73) | |||
| Potential Upside | 8.8 |
Additional Tools for Cryoport Stock Analysis
When running Cryoport's price analysis, check to measure Cryoport's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cryoport is operating at the current time. Most of Cryoport's value examination focuses on studying past and present price action to predict the probability of Cryoport's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cryoport's price. Additionally, you may evaluate how the addition of Cryoport to your portfolios can decrease your overall portfolio volatility.